1.
Journal of Leukemia & Lymphoma
;
(12): 637-640, 2020.
Artigo
em Chinês
| WPRIM
| ID: wpr-862885
RESUMO
The intestinal flora in patients with leukemia is significantly different from healthy people. Some studies have found that intestinal flora can participate in leukemia progression by regulating the body's immune system and hematopoietic system and affecting the metabolic function, but the underlying molecular mechanism is not clear. Maintaining the intestinal microecological balance and exploring intestinal microbes that can be used as therapeutic targets have a profound significance for prolonging the survival of leukemia patients.